ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Epstein Petition Seeks Broder’s Removal As NCI Director

February 5, 1993

Realities Of The 1989 Budget: Number Of grants Cut By 250, Only 255 Of Approved Will By Funded

October 7, 1988

Obama Signs Law Authorizing $126 Million Over 10 Years for Pediatric Research

April 11, 2014

Cancer death rate dropping 1.1 percent a year, annual report finds.

October 7, 2005

Clinical Trials Approved By NCI

November 26, 2010

In Brief: NCI’s Cutler Clarifies Policy On Release Of Survey Data, Tape Duplicates Will Be Available At Cost

September 6, 1974